Dr. Tseng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1570 N 115th St
Seattle, WA 98133Phone+1 206-306-2804Fax+1 617-975-0935
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2010 - 2014
- Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2010
- Harvard Medical SchoolClass of 2009
Certifications & Licensure
- WA State Medical License 2014 - 2025
- MA State Medical License 2011 - 2016
- American Board of Radiology Radiation Oncology
Clinical Trials
- Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma Start of enrollment: 2017 Aug 02
Publications & Presentations
PubMed
- The seemingly contradictory roles of radiation as focal to systemic therapy in hematologic malignancies.Yolanda D Tseng, N George Mikhaeel
Seminars in Radiation Oncology. 2025-01-01 - Treatment Options for IDH-Mutant Malignant Gliomas.Sasha N Swensen, Karl Cristie F Figuracion, Vyshak A Venur, Samuel Emerson, Yolanda D Tseng
Current Treatment Options in Oncology. 2024-12-01 - A phase 2 study of frontline pembrolizumab in follicular lymphoma.Carrie Ho, Songli Zhu, Ted Gooley, Taranjit S Gujral, Ryan C Lynch
Ejhaem. 2024-12-01
Abstracts/Posters
- Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell LymphomasYolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic TrialsYolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell TherapyYolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Society for Palliative Radiation Oncology: Report from the Fifth Annual Meeting (2018)February 1st, 2019
- Irradiation Safe, Effective as Chemotherapy Before Cell Transplant in Mantle Cell LymphomaOctober 23rd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: